γδ T cells and their potential for immunotherapy

Area of Science:

• Immunology
• Cell Biology
• Immunotherapy

Background:

• Vγ9Vδ2 T cells are a major human peripheral blood γδ T cell subset.
• They recognize microbial and endogenous non-peptide antigens via their T cell receptor (TCR).
• Recognition is independent of antigen-presenting cells and MHC molecules.

Purpose of the Study:

• To review the immunological properties of Vγ9Vδ2 T cells.
• To elucidate their non-peptide antigen recognition mechanisms.
• To summarize the outcomes of Vγ9Vδ2 T cell-based therapies.

Main Methods:

• Review of existing literature on Vγ9Vδ2 T cell immunology and therapies.
• Analysis of TCR-dependent recognition mechanisms.
• Evaluation of preclinical and clinical trial data for immunotherapies.

Main Results:

• Vγ9Vδ2 T cells mediate innate immunity and exhibit potent anti-tumor cytotoxicity.
• They bridge innate and adaptive immunity via NK receptors and antigen presentation.
• Preclinical and clinical trials demonstrate potential for Vγ9Vδ2 T cell-based treatments.

Conclusions:

• Vγ9Vδ2 T cells possess unique antigen recognition capabilities.
• Their dual role in innate and adaptive immunity is significant.
• Vγ9Vδ2 T cells represent a promising therapeutic strategy for infections and malignancies.